News for Kyverna Therapeutics Inc Stock (KYTX)

Kyverna Therapeutics to Present at the 43rd Annual J. P. Morgan Healthcare Conference

PRNewsWire • Monday

Levi & Korsinsky Notifies Shareholders of Kyverna Therapeutics, Inc. (KYTX) of a Class Action Lawsuit and an Upcoming Deadline

Accesswire • Monday

KYTX Announcement: Kessler Topaz Meltzer & Check, LLP Encourages Kyverna Therapeutics, Inc. Investors to Contact the Firm About Securities Fraud Class Action Lawsuit

Accesswire • Monday

Kyverna Therapeutics, Inc. (KYTX) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

PRNewsWire • Monday

Kyverna Therapeutics Inc Is Being Sued For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm

Accesswire • Monday

KYTX Investors Have Opportunity to Lead Kyverna Therapeutics, Inc. Securities Fraud Lawsuit Filed by the Schall Law Firm

PRNewsWire • Monday

KYTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Kyverna Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Accesswire • Monday

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – KYTX

Accesswire • 01/05/25

KYTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Kyverna Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!

Accesswire • 01/05/25

ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – KYTX

GlobeNewsWire • 01/05/25

Levi & Korsinsky Notifies Shareholders of Kyverna Therapeutics, Inc.(KYTX) of a Class Action Lawsuit and an Upcoming Deadline

Accesswire • 01/04/25

KYTX Announcement: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against Kyverna Therapeutics, Inc.

PRNewsWire • 01/04/25

Kyverna Therapeutics Inc Is Being Sued For Securities Law Violations And Affected Investors Are Encouraged To Contact The Schall Law Firm

Accesswire • 01/04/25

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTX

Accesswire • 01/04/25

Investors who Lost Money on Kyverna Therapeutics, Inc. (KYTX) Should Contact Levi & Korsinsky about Pending Class Action - KYTX

Accesswire • 01/03/25

The Schall Law Firm Urges Shareholders With Losses To Join A Securities Fraud Case Against Kyverna Therapeutics Inc

Accesswire • 01/03/25

Shareholders that lost money on Kyverna Therapeutics, Inc. (KYTX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

Accesswire • 01/03/25

KYTX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Kyverna Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Accesswire • 01/03/25

Shareholders that lost money on Kyverna Therapeutics, Inc.(KYTX) should contact The Gross Law Firm about pending Class Action - KYTX

PRNewsWire • 01/02/25

Kyverna Therapeutics, Inc. Is Being Sued For Securities Law Violations And Affected Investors Are Invited To Contact The Schall Law Firm

Accesswire • 01/02/25

Shareholders that Lost Money on Kyverna Therapeutics, Inc. (KYTX) Should Contact Levi & Korsinsky About Pending Class Action - KYTX

Accesswire • 01/02/25

KYTX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Kyverna Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Accesswire • 01/02/25

KYTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Kyverna Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Accesswire • 01/02/25

Kyverna Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Kyverna Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 7, 2025 - KYTX

Accesswire • 01/02/25

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – KYTX

GlobeNewsWire • 01/01/25